Mark S. Varney
Corporate Officer/Principal bei The University of Southampton
Profil
Mark S.
Varney is currently a Lecturer at The University of Southampton.
Previously, he worked as a Research Director at Anaxsys Technology Ltd.
He obtained an undergraduate degree from The University of Southampton.
Aktive Positionen von Mark S. Varney
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of Southampton | Corporate Officer/Principal | 17.12.2009 |
Ehemalige bekannte Positionen von Mark S. Varney
| Unternehmen | Position | Ende |
|---|---|---|
Anaxsys Technology Ltd.
 Anaxsys Technology Ltd. Medical SpecialtiesHealth Technology Anaxsys Technology Ltd. manufactures and markets respiratory diagnostic products. Its products monitoring, screening and diagnostics in the areas of vital signs, asthma, sleep apnoea and lung cancer. The firm offers respiR8, a respiratory rate counter that provides early indication of patient deterioration, as well as information of respiratory rate to healthcare professionals to monitor, diagnose, and treat patients. The company was founded by Deryk Williams in January 2002 and is headquartered in Send, the United Kingdom. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Mark S. Varney
| The University of Southampton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Anaxsys Technology Ltd.
Anaxsys Technology Ltd. Medical SpecialtiesHealth Technology Anaxsys Technology Ltd. manufactures and markets respiratory diagnostic products. Its products monitoring, screening and diagnostics in the areas of vital signs, asthma, sleep apnoea and lung cancer. The firm offers respiR8, a respiratory rate counter that provides early indication of patient deterioration, as well as information of respiratory rate to healthcare professionals to monitor, diagnose, and treat patients. The company was founded by Deryk Williams in January 2002 and is headquartered in Send, the United Kingdom. | Health Technology |
